-
Expansion of Oral Fluid Testing of Behavioral Health Drugs
Aegis’ oral fluid testing menu has been expanded to allow providers the option to test for many additional medications and/or illicit drugs. The enhancement…
-
Review of New InterAct Rx Analyte Positivity
In 2015, Aegis Sciences Corporation began to seek out a way to expand the clinical information that could be provided through definitive testing. With…
-
Broaden your Understanding: Benefits of the InterACT Rx™ Expansion
In 2015, Aegis Sciences Corporation began to seek out a way to expand the clinical information that could be provided through definitive testing. With…
-
Introduction to Pharmacogenetic (PGx) for Pain Management
Aegis offers pharmacogenetic testing focusing on medication/gene pairs that are supported by clinical guidelines, FDA-approved labeling, or clinical studies…
-
Introduction to PGx for Behavioral Health
Aegis offers pharmacogenetic testing, with a majority of the available tests focusing on medications prescribed in behavioral health. The testing menu…
-
Kratom: New Year, New Insights
Q: What is the latest information Aegis can provide about kratom? What other drugs are most commonly present in urine specimens testing positive for kratom? A:…
-
What Did My Patient Actually Take? An Overview of Benzodiazepine Results
Our series on interpreting unexpected results concludes with a discussion on the interpretation of benzodiazepine results from Aegis Sciences Corporation.…
